# Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma

> **NCT05833594** · — · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma
- Chemoradiotherapy
- Immunonutrition
- Inoperable

## Interventions

- **DIETARY_SUPPLEMENT:** Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs

## Key facts

- **NCT ID:** NCT05833594
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05833594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05833594, "Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05833594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
